GSK resolves patent lawsuit against Pfizer over RSV vaccines
British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna
In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field ...
Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 ...
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
Feds probe disputed tip Pfizer held Covid vaccine results until after 2020 vote: WSJ
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
Pharmaceutical Technology on MSN3 天
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK
Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
葛兰素史克举报辉瑞曾推迟发布新冠疫苗消息，美国检方介入调查
据知情人士透露，在去年11月唐纳德·特朗普 (Donald Trump)赢得总统大选后不久，英国制药商 葛兰素史克 (GSK)就向曼哈顿的联邦检察官提出了一项不同寻常的指控。 曾经在葛兰素史克的竞争对手 辉瑞公司 ...
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
Zacks.com on MSN2 天
PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo
The latest decision makes Pfizer's Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of ...
Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Pfizer Stock Slips After Report on Vaccine Timing Probe
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
Reuters3 天
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
April 1 (Reuters) - The European Commission approved Pfizer's (PFE.N), opens new tab respiratory syncytial virus vaccine for the prevention of lower respiratory tract disease caused by RSV in ...